Bildkälla: Stockfoto

Lipigon: CTA for Phase II Submitted - Redeye

Redeye provides a brief comment on the planned start of the phase II trial of Lipisense.

Redeye provides a brief comment on the planned start of the phase II trial of Lipisense.
Börsvärldens nyhetsbrev
ANNONSER